Natera · 1 day ago
Event Marketing Manager-WEST
Natera is a global leader in cell-free DNA testing, focusing on oncology and personalized genetic testing. The Regional Event Manager will be responsible for planning and executing regional marketing events to enhance awareness and adoption of Natera's oncology products.
BiotechnologyGeneticsHealth DiagnosticsMedicalWomen's
Responsibilities
Event planning and coordination - Plan, organize, and execute regional marketing events, including conferences, trade shows, symposia, and advisory boards
Vendor and budget management - Manage relationships with external vendors. Negotiate contracts and monitor deliverables to maintain high-quality standards
Coordinate event logistics - Deploy materials and speaker, attendee communications. Ensure compliance with healthcare regulations and company policies for all event-related activities
Marketing support and analytics - Collaborate with the key account and area marketing team to support lead generation and brand awareness through event strategy. Partner with marketing to ensure consistent branding and messaging across all event materials. Track event ROI through attendee engagement, lead quality, and follow-up effectiveness
Qualification
Required
Bachelor's degree in a related field required (B.A. or B.S.)
Minimum of 5 years in healthcare product marketing, event marketing & management or sales
Experience in life sciences, health technology, or diagnostics is required
High integrity and strong interpersonal skills to build lasting relationships with stakeholders
Excellent project management skills with strong attention to detail and ability to manage timelines effectively
Preferred
Oncology experience is strongly preferred
Benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Recent News
2026-01-08
Company data provided by crunchbase